Quantbot Technologies LP purchased a new stake in Steris PLC (NYSE:STE) during the third quarter, HoldingsChannel.com reports. The fund purchased 4,563 shares of the medical equipment provider’s stock, valued at approximately $522,000.
A number of other institutional investors have also bought and sold shares of STE. Steward Partners Investment Advisory LLC raised its stake in Steris by 118.0% in the third quarter. Steward Partners Investment Advisory LLC now owns 909 shares of the medical equipment provider’s stock valued at $104,000 after buying an additional 492 shares in the last quarter. First Hawaiian Bank acquired a new stake in Steris in the third quarter valued at $106,000. Point72 Hong Kong Ltd acquired a new stake in Steris in the second quarter valued at $116,000. Fort L.P. acquired a new stake in Steris in the second quarter valued at $121,000. Finally, Parallel Advisors LLC raised its stake in Steris by 480.4% in the third quarter. Parallel Advisors LLC now owns 1,364 shares of the medical equipment provider’s stock valued at $156,000 after buying an additional 1,129 shares in the last quarter. Institutional investors own 88.35% of the company’s stock.
Shares of STE stock opened at $113.94 on Friday. The stock has a market cap of $9.98 billion, a price-to-earnings ratio of 26.48 and a beta of 1.05. Steris PLC has a 1 year low of $82.88 and a 1 year high of $121.67. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.01 and a current ratio of 2.63.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 21st. Shareholders of record on Wednesday, November 28th will be issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 1.19%. The ex-dividend date is Tuesday, November 27th. Steris’s payout ratio is 32.77%.
In other Steris news, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, November 7th. The stock was sold at an average price of $120.50, for a total transaction of $1,205,000.00. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Michael J. Tokich sold 34,500 shares of the firm’s stock in a transaction dated Wednesday, November 7th. The stock was sold at an average price of $119.16, for a total value of $4,111,020.00. Following the transaction, the insider now directly owns 64,958 shares in the company, valued at approximately $7,740,395.28. The disclosure for this sale can be found here. Company insiders own 2.38% of the company’s stock.
STE has been the topic of a number of analyst reports. Zacks Investment Research upgraded Steris from a “sell” rating to a “hold” rating in a research note on Tuesday, October 9th. Sidoti raised their price target on Steris from $155.00 to $157.00 and gave the company a “buy” rating in a research note on Thursday. Finally, KeyCorp raised their price target on Steris from $120.00 to $132.00 and gave the company an “overweight” rating in a research note on Tuesday, November 13th. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $124.71.
TRADEMARK VIOLATION NOTICE: This news story was first published by BBNS and is the property of of BBNS. If you are viewing this news story on another publication, it was illegally stolen and republished in violation of U.S. & international copyright law. The legal version of this news story can be read at https://baseballnewssource.com/2018/12/08/quantbot-technologies-lp-takes-522000-position-in-steris-plc-ste/3064248.html.
Steris Company Profile
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Further Reading: Different Types of Derivatives
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.